• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白 A1 和低密度脂蛋白作为绝经后乳腺癌眼内转移的危险因素。

Apolipoprotein A1 and Low-Density Lipoprotein as Risk Factors for Intraocular Metastases in Postmenopausal Breast Cancer.

机构信息

Department of Ophthalmology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province, China.

出版信息

Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820984180. doi: 10.1177/1533033820984180.

DOI:10.1177/1533033820984180
PMID:33413027
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7797569/
Abstract

BACKGROUND

The outcomes of patients with postmenopausal breast cancer(PBC) can be improved through the early detection of intraocular metastases(IOMs). In this study, we investigated patients with PBC, and compared those with IOMs with those with non-intraocular metastases(NIOMs) in terms of blood lipid levels, and then differentiated the risk factors associated with IOMs.

METHODS

Student's t-test and a chi-square test were used to discriminate between the IOMs and NIOMs groups. After establishing a Poisson regression model to analyze risk factors, we plotted receiver operating characteristic curves(ROC) to assess the quality of risk factors predicting IOMs.

RESULTS

The incidence of IOMs in PBC was 1.16%. There was no significant difference in terms of histopathology between the 2 groups. The levels of total cholesterol (TC), apolipoprotein A1(APOA1) and low-density lipoprotein(LDL) in IOMs were significantly lower than in NIOMs groups. Poisson regression suggested that low levels of APOA1 and LDL were risk factors for IOMs (P = 0.002 and P < 0.001, respectively). ROC curve analysis demonstrated that the cut-off values of APOA1 and LDL were 1.025 g/L and 2.415 mmol/L. The highest prediction accuracy for IOMs involved the combination of APOA1 and LDL (AUC = 0.881, P < 0.001).

CONCLUSION

Our research demonstrates that low levels of APOA1 and LDL efficiently predict IOMs in PBC as risk factors, and the combination of APOA1 and LDL was more predictive than single factors.

摘要

背景

通过早期发现眼内转移(IOM),可以改善绝经后乳腺癌(PBC)患者的预后。本研究旨在探讨 PBC 患者的临床特征,比较 IOM 与非眼内转移(NIOM)患者的血脂水平,并分析与 IOM 相关的危险因素。

方法

采用学生 t 检验和卡方检验对 IOM 与 NIOM 组进行比较。建立泊松回归模型分析危险因素,绘制受试者工作特征曲线(ROC)评估危险因素预测 IOM 的效能。

结果

PBC 患者 IOM 的发生率为 1.16%。两组间组织病理学无显著差异。IOM 组的总胆固醇(TC)、载脂蛋白 A1(APOA1)和低密度脂蛋白(LDL)水平明显低于 NIOM 组。泊松回归分析提示 APOA1 和 LDL 水平低是 IOM 的危险因素(P = 0.002 和 P < 0.001)。ROC 曲线分析表明 APOA1 和 LDL 的截断值分别为 1.025 g/L 和 2.415 mmol/L。APOA1 和 LDL 联合预测 IOM 的准确性最高(AUC = 0.881,P < 0.001)。

结论

本研究表明,APOA1 和 LDL 水平低是 PBC 患者发生 IOM 的有效危险因素,且二者联合预测价值优于单一因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/7797569/6bb7ee1504aa/10.1177_1533033820984180-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/7797569/aedf8a1d966c/10.1177_1533033820984180-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/7797569/6bb7ee1504aa/10.1177_1533033820984180-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/7797569/aedf8a1d966c/10.1177_1533033820984180-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dced/7797569/6bb7ee1504aa/10.1177_1533033820984180-fig2.jpg

相似文献

1
Apolipoprotein A1 and Low-Density Lipoprotein as Risk Factors for Intraocular Metastases in Postmenopausal Breast Cancer.载脂蛋白 A1 和低密度脂蛋白作为绝经后乳腺癌眼内转移的危险因素。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033820984180. doi: 10.1177/1533033820984180.
2
Carbohydrate antigen 125, carbohydrate antigen 15-3 and low-density lipoprotein as risk factors for intraocular metastases in postmenopausal breast cancer.糖抗原 125、糖抗原 15-3 和低密度脂蛋白作为绝经后乳腺癌眼内转移的危险因素。
Medicine (Baltimore). 2021 Oct 29;100(43):e27693. doi: 10.1097/MD.0000000000027693.
3
Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.在常规临床血脂检测前联合使用载脂蛋白B/载脂蛋白A1比值和非高密度脂蛋白胆固醇预测冠心病
Coron Artery Dis. 2014 Aug;25(5):433-8. doi: 10.1097/MCA.0000000000000100.
4
Low serum level of apolipoprotein A1 may predict the severity of COVID-19: A retrospective study.载脂蛋白 A1 血清水平低可能预示着 COVID-19 的严重程度:一项回顾性研究。
J Clin Lab Anal. 2021 Aug;35(8):e23911. doi: 10.1002/jcla.23911. Epub 2021 Jul 14.
5
Predictive value of preoperative platelet-to-albumin ratio and apolipoprotein B-to-apolipoprotein A1 ratio for osteosarcoma in children and adolescents: a retrospective study of 118 cases.术前血小板/白蛋白比值和载脂蛋白 B/载脂蛋白 A1 比值对儿童和青少年骨肉瘤的预测价值:118 例回顾性研究。
BMC Cancer. 2022 Jan 27;22(1):113. doi: 10.1186/s12885-022-09223-x.
6
Plasma oxidized low-density lipoprotein is an independent risk factor in young patients with coronary artery disease.血浆氧化型低密度脂蛋白是青年冠心病患者的独立危险因素。
Dis Markers. 2011;31(5):295-301. doi: 10.3233/DMA-2011-0832.
7
Effect of hormone replacement therapy, tibolone and raloxifene on serum lipids, apolipoprotein A1, apolipoprotein B and lipoprotein(a) in Greek postmenopausal women.激素替代疗法、替勃龙和雷洛昔芬对希腊绝经后妇女血清脂质、载脂蛋白A1、载脂蛋白B和脂蛋白(a)的影响。
Gynecol Endocrinol. 2004 May;18(5):244-57. doi: 10.1080/09513590410001715207.
8
Plasma apolipoprotein A1 levels at diagnosis are independent prognostic factors in invasive ductal breast cancer.诊断时的血浆载脂蛋白A1水平是浸润性导管癌的独立预后因素。
Discov Med. 2017 Apr;23(127):247-258.
9
[A case-control study on the association between serum lipid level and the risk of breast cancer].血清脂质水平与乳腺癌风险关联的病例对照研究
Zhonghua Yu Fang Yi Xue Za Zhi. 2016 Dec 6;50(12):1091-1095. doi: 10.3760/cma.j.issn.0253-9624.2016.12.013.
10
Apolipoprotein A1-Unique Peptide as a Diagnostic Biomarker for Acute Ischemic Stroke.载脂蛋白A1独特肽作为急性缺血性中风的诊断生物标志物
Int J Mol Sci. 2016 Mar 28;17(4):458. doi: 10.3390/ijms17040458.

引用本文的文献

1
Prediction model of ocular metastasis from primary liver cancer: Machine learning-based development and interpretation study.基于机器学习的原发性肝癌眼转移预测模型:开发与解释研究。
Cancer Med. 2023 Oct;12(20):20482-20496. doi: 10.1002/cam4.6540. Epub 2023 Oct 5.
2
Apolipoproteins: New players in cancers.载脂蛋白:癌症中的新角色。
Front Pharmacol. 2022 Nov 25;13:1051280. doi: 10.3389/fphar.2022.1051280. eCollection 2022.
3
Effect of Serum Lipid Profile on the Risk of Breast Cancer: Systematic Review and Meta-Analysis of 1,628,871 Women.

本文引用的文献

1
Dyslipidemia and Meibomian Gland Dysfunction: Utility of Lipidomics and Experimental Prospects with a Diet-Induced Obesity Mouse Model.血脂异常与睑板腺功能障碍:脂质组学的应用及饮食诱导肥胖小鼠模型的实验前景。
Int J Mol Sci. 2019 Jul 17;20(14):3505. doi: 10.3390/ijms20143505.
2
HDL and LDL: Potential New Players in Breast Cancer Development.高密度脂蛋白和低密度脂蛋白:乳腺癌发展中潜在的新因素。
J Clin Med. 2019 Jun 14;8(6):853. doi: 10.3390/jcm8060853.
3
Emerging roles of low-density lipoprotein in the development and treatment of breast cancer.
血清脂质谱对乳腺癌风险的影响:对1,628,871名女性的系统评价和荟萃分析
J Clin Med. 2022 Aug 2;11(15):4503. doi: 10.3390/jcm11154503.
低密度脂蛋白在乳腺癌发展和治疗中的新作用。
Lipids Health Dis. 2019 Jun 10;18(1):137. doi: 10.1186/s12944-019-1075-7.
4
Systemic immune-inflammation index and ultrasonographic classification of breast imaging-reporting and data system predict outcomes of triple-negative breast cancer.全身免疫炎症指数及乳腺影像报告和数据系统的超声分类可预测三阴性乳腺癌的预后。
Cancer Manag Res. 2019 Jan 17;11:813-819. doi: 10.2147/CMAR.S185890. eCollection 2019.
5
Association of Body Fat and Risk of Breast Cancer in Postmenopausal Women With Normal Body Mass Index: A Secondary Analysis of a Randomized Clinical Trial and Observational Study.绝经后正常体重指数女性体脂与乳腺癌风险的关联:一项随机临床试验和观察性研究的二次分析。
JAMA Oncol. 2019 Feb 1;5(2):155-163. doi: 10.1001/jamaoncol.2018.5327.
6
Increased High-Density Lipoprotein Levels Associated with Age-Related Macular Degeneration: Evidence from the EYE-RISK and European Eye Epidemiology Consortia.高密度脂蛋白水平升高与年龄相关性黄斑变性相关:来自 EYE-RISK 和欧洲眼流行病学联盟的证据。
Ophthalmology. 2019 Mar;126(3):393-406. doi: 10.1016/j.ophtha.2018.09.045. Epub 2018 Oct 10.
7
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
8
Cancers of the eye.眼部肿瘤。
Cancer Metastasis Rev. 2018 Dec;37(4):677-690. doi: 10.1007/s10555-018-9762-9.
9
Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.葡萄膜转移瘤:基于原发肿瘤起源的1111例患者中2214个肿瘤的临床特征及生存结果
Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):81-90. doi: 10.4103/meajo.MEAJO_6_18.
10
A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease.一个包含程序性死亡受体1(PD-1)、白细胞介素2受体α(IL-2Rα)、白细胞介素10(IL-10)和糖类抗原15-3(CA15-3)作为生物标志物的检测组合,用于鉴别乳腺癌和良性乳腺疾病。
Cancer Manag Res. 2018 Jun 26;10:1749-1761. doi: 10.2147/CMAR.S160452. eCollection 2018.